Mankind Pharma Clears Broadway Hospitality Sale, Plans Netherlands R&D Vehicle

MT Newswires Live
07/13

Mankind Pharma (BOM:543904, NSE:MANKIND) approved the sale of its wholly owned subsidiary, Broadway Hospitality Services, according to an exchange filing Saturday.

The company will sell its entire stake in Broadway to AKRK Projects and Partners for 4.90 billion rupees, subject to closing adjustments.

The transaction is expected to be completed within 90 days as part of Mankind Pharma's strategy to divest non-core assets.

Separately, Mankind Pharma approved the incorporation of a wholly owned subsidiary in the Netherlands as a special purpose vehicle to hold R&D investments and support business development in niche therapies.

The company plans to invest up to 5 million euros in the Dutch unit in one or more tranches to fund its setup, operations, procurement, and future investments.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10